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Groningen, Amsterdam, Nijmegen, Leiden, Zwolle, the NetherlandsBackground and Aims: Patients with Lynch syndrome (LS) undergo regular surveillance by colonoscopy because of
an increased risk of colorectal neoplasia, particularly in the proximal colon. Chromoendoscopy (CE) has been reported
to improve neoplasia detection compared with conventional white-light endoscopy (WLE), but evidence is limited. Our
aimwas to investigate the effect of CE in the proximal colon on detection of neoplastic lesions during surveillance in LS.
Methods: This was a multicenter prospective randomized controlled trial of 246 patients with LS who were
randomly assigned (1:1) to conventional WLE (n Z 123) or colonoscopy with CE in the proximal colon (n Z
123), stratified for previous colorectal adenomas and enrolling center. Two years after baseline colonoscopy, pa-
tients underwent colonoscopy with CE in the proximal colon. The primary outcome was the proportion of pa-
tients with at least one neoplastic lesion at baseline and after 2 years.
Results: Neoplasia detection rates at baseline colonoscopy were 27% for WLE versus 30% for CE (odds ratio [OR],
1.23; 95% confidence interval [CI], 0.69-2.2; PZ .56). In the proximal colon, neoplasia detection rates were 16%
for WLE versus 24% for CE (OR, 1.6; 95% CI, 0.9-3.1; PZ .13). Total procedure time was 9 minutes longer in the
CE group. At follow-up after 2 years, neoplasia detection rates were similar in both groups: 26% for the original
WLE group versus 28% for the CE group (OR, 1.1; P Z .81).
Conclusions: CE in the proximal colon for LS surveillance was not superior toWLE with respect to the initial detec-
tion of neoplasia, and not associated with reduced neoplasia detection rates after 2 years. The value of CE remains to
be established. (Clinical trial registration number: NCT00905710.) (Gastrointest Endosc 2019;90:624-32.)INTRODUCTION inherited mutations affecting any of 4 DNA mismatchLynch syndrome (LS) is the most common hereditary
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Haanstra et al Chromoendoscopy and colorectal neoplasia detection in Lynch syndromehave a high risk of developing CRC and various extraco-
lonic malignancies.1,2
Regular colonoscopy every 1 to 3 years with removal
of adenomatous polyps is universally recommended.
Removal of these precursor lesions reduces CRC risk and
CRC-related mortality in LS by at least 50%.3-5 Nevertheless,
up to 46% of patients still develop interval CRCs within the
recommended surveillance intervals.6 Up to half of
adenomas may be missed by surveillance colonoscopy.4,7
Compared with patients at average risk for CRC, adenomas
in patients with LS are more likely to have a nonpolypoid
endoscopic appearance, especially in the proximal colon,
and many of these proximal adenomas already show
high-grade dysplasia when still small.8,9 Because these le-
sions are easily overlooked,10 it is of utmost importance
to optimize adenoma detection.
Surveillance in LS is generally performed using white-
light colonoscopy (WLE). In recent years, new endoscopic
techniques have been investigated to optimize detection of
colorectal neoplasia in LS.11 One of these techniques is
dye-spray chromoendoscopy (CE). CE is a relatively easy
technique without the need for special endoscopes, using
topically applied dye spray to facilitate visualization of fine
mucosal surface details.12 CE has been shown to increase
the detection of neoplasia in the colorectum in the
general population,13-15 in patients with inflammatory
bowel disease,16,17 and in patients with LS.7,18-20 The Euro-
pean Society of Gastrointestinal Endoscopy recommends
the use of CE in LS but acknowledges that the recommen-
dation is based on low-quality evidence.15 Previous studies
suggest superiority of CE over WLE in the detection of
neoplastic lesions, although convincing data are lacking.
Drawbacks of CE include a prolonged procedure time,
increased detection of clinically irrelevant non-neoplastic
lesions, and the need for experience in the technique.
Although it is likely that enhancing neoplasia detection in
LS using CE will result in a reduction of neoplastic lesions
at subsequent procedures, this has never been studied.
The aim of the present study was to compare neoplasia
detection rates using CE versus WLE in patients with LS un-
der endoscopic surveillance.METHODS
Study design and participants
This study was a prospective randomized controlled
parallel trial in 6 centers in the Netherlands. Proven or obli-
gate carriers of an MMR gene mutation in MLH1, MSH2/EP-
CAM, or MSH6 aged between 20 and 70 years of age were
eligible. PMS2mutation carriers were not included because
the risk of colorectal neoplasia is much lower in these pa-
tients in comparison with carriers of mutations in the other
genes.5 Exclusion criteria were previous colon surgery or
the presence of any psychologic, familial, sociologic, or
geographic condition potentially hampering compliancewww.giejournal.orgwith the study protocol and follow-up schedule. The study
protocol was approved by the local medical ethical com-
mittee of the University Medical Center Groningen on
May 8, 2008, and subsequently in all other participating
centers. Patients were recruited between July 2008 and
June 2014. The last colonoscopy was performed in May
2016. All participants provided written informed consent.
Randomization and masking
Patients were enrolled by clinicians of the participating
centers. Patients were randomly assigned (1:1) to conven-
tional WLE or colonoscopy using CE. The endoscopic sur-
veillance technique to be used (WLE or CE) was marked
and placed in blocks with a fixed size of 10 sealed opaque
envelopes that were created in advance. After inclusion
and before the procedure, 1 envelope was drawn and
opened just before colonoscopy. Randomization was strat-
ified for previous colorectal adenomas and enrolling cen-
ter. The endoscopists could not be masked to the
endoscopic strategy because CE requires the application
of dye spray as part of the technique. Twenty-four months
after the baseline colonoscopy procedure, all patients un-
derwent colonoscopy with CE. Deviation from the prede-
termined interval of 24 months was allowed at the
discretion of participating endoscopists to a maximum of
6 months, so 18 to 30 months. The study design is shown
in Figure 1.
Procedures
All procedures were performed by experienced gastro-
enterologists, preferably one dedicated endoscopist in
each center, with extensive experience in CE procedures.
Cecal intubation was confirmed by documented identifica-
tion of the ileocecal valve and appendiceal orifice. In the
WLE group, the entire colon was examined by white-light
colonoscopy. In the CE group, after cecal intubation, a
dye-spray catheter was used to spray a 0.4% indigo carmine
solution onto the mucosal surface of the proximal colon.
This was performed in segments of 10 cm during gradual
withdrawal from the cecum up to the splenic flexure.
The distal colon in the CE group was inspected with con-
ventional WLE.
In both arms, bowel preparation was based on oral
lavage using polyethylene glycol electrolyte solution or a
similar preparation according to local practice of the insti-
tution. To evaluate the quality of bowel preparation, a
semiquantitative grading scale was used, as in earlier
studies.18,20 The overall quality of bowel preparation was
rated good (only fluid residues, which could be aspirated,
offering 100% visualization), fair (>90% visualization), and
poor (<90% visualization). Bowel preparation was consid-
ered adequate in patients with good or fair bowel prepara-
tion. Patients with poor bowel preparation were excluded
from analysis as well as patients in whom the cecum was
not reached. A minimal withdrawal time of 6 minutes
was considered to be required in line with internationalVolume 90, No. 4 : 2019 GASTROINTESTINAL ENDOSCOPY 625
92 had CE
at colonscopy after 2 years
94 had CE
at colonoscopy after 2 years
21 excluded*
115 had CE
at baseline colonoscopy
8 excluded
249 patients assessed
for eligibility
3 ineligible
1 no MMR mutation
1 previous surgery
age > 70
246 randomly
assigned
123 allocated to WLE
7 excluded
Baseline
analysis
123 allocated to CE
Follow-up at
2 years
analysis
24 excluded#
116 had WLE
at baseline colonoscopy
Figure 1. Flowchart showing the study design. #Reasons for exclusion were colectomy (n Z 1), severe comorbidity (n Z 1), death not related to the
study (nZ 1), serious deviation from predefined interval (nZ 12), and poor bowel preparation (nZ 9). *Reasons for exclusion were serious deviation
from predefined interval (n Z 13) and poor bowel preparation (n Z 8). CE, Chromoendoscopy; MMR, mismatch repair; WLE, white-light endoscopy.
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TABLE 1. Demographics and clinical characteristics of the patients
with LS at baseline
White-light
endoscopy
(n[116)
Chromoendoscopy
(n[115)
Age (years), mean (SD) 46 (11) 46 (12)
Male gender, n (%) 46 (39) 49 (43)
Mutation type, n (%)
MLH1 26 (22) 33 (29)
MSH2 40 (34) 36 (31)
MSH6 49 (42) 42 (36)
EPCAM 1 (1) 4 (4)
First colonoscopy 22 (19) 22 (19)
Previous adenoma(s) 43 (37) 46 (40)
LS, Lynch syndrome; SD, standard deviation.
Haanstra et al Chromoendoscopy and colorectal neoplasia detection in Lynch syndromeguidelines.21 All lesions identified were classified according
to the Paris classification,22 size, and segment of the colon.
The location of a polyp was considered proximal when the
polyp was detected in the part of the colon proximal from
the splenic flexure. Lesion size was estimated in
millimeters. All amenable lesions were removed by snare
polypectomy during procedures and sampled for
histopathologic examination. Total procedure time was
defined as the time between introduction and extubation
of the endoscope. Withdrawal time was defined as the
total extubation time, including spraying of indigo
carmine minus time spent on polypectomy.
Histologic samples were assessed by a gastrointestinal
specialist pathologist at each participating center. A lesion
was considered neoplastic if histology showed either
adenocarcinoma or adenoma. Adenomas were classified
as tubular, tubulovillous, villous, or serrated. The degree
of dysplasia in adenomas was classified as low grade or
high grade. Adenomas (1) larger than 1 cm; and/or (2)
with high-grade dysplasia; and/or (3) with tubulovillous
or villous architecture, and adenocarcinomas were
considered as advanced neoplasia. A lesion was
considered non-neoplastic when histology showed no
dysplasia and classified as hyperplastic or serrated (desig-
nated sessile serrated polyp [SSP]), lymphoid tissue, or
normal mucosa.
Outcomes
The primary outcomewas the proportion of patients with
at least 1 neoplastic lesion (neoplasia detection rate) at base-
line and at the follow-up colonoscopy after 2 years. Sub-
group analysis was performed for findings in the proximal
colon. Secondary endpoints were the proportion of patients
with one or more polyps (polyp detection rate); mean num-
ber of neoplastic lesions per colonoscopy; median proced-
ure times; colectomy rate (defined as the proportion of
patients requiring a colectomy), and adverse event rate
(defined as the proportion of patients with immediate or de-
layed postpolypectomy bleeding or perforation).
Statistical analysis
When WLE was used in patients with LS, the
neoplasia detection rate was around 20% in previous
studies3,19,23,24 with a 2-fold increment in detection rate
when using pancolonic CE.18-20 Based on these data, we
calculated that 91 patients were required in each group
(80% power, 2-sided a of 5%).25 No data were available
from the literature that allowed us to estimate the yield
of CE in the proximal colon. The aim was to include at
least 10% additional patients in each group to correct for
expected drop-out or cases lost to follow-up. Neoplasia
detection rates and polyp detection rates were compared
using the Fisher exact test with Mantel-Haenszel statistic
to estimate odds ratio (OR) and 95% confidence intervals
(CIs). Mean numbers of neoplastic lesions per colonoscopy
and median procedure times were compared using thewww.giejournal.orgMann-Whitney test. Adverse event rates and colectomy
rates were compared using the c2 test. Outcomes at
follow-up after 2 years were analyzed on a per protocol ba-
sis, defined as the participants in both groups who under-
went the assigned intervention, completed both the
baseline colonoscopy and the colonoscopy after 2 years,
and had no other protocol violations. Two-sided P values
of less than .05 were considered statistically significant.
All statistical analyses were performed using IBM Statistical
Package for the Social Sciences (SPSS) version 23.0.
This study was registered in the ClinicalTrials.gov regis-
try with identifier NCT00905710.RESULTS
Between July 22, 2008, and June 27, 2014, 249 patients
were assessed for eligibility, and 246 patients fulfilling the in-
clusion criteria were randomized to undergoWLE (nZ 123)
or CE (n Z 123). After randomization, 15 patients were
excluded because of poor bowel preparation or incomplete
colonoscopy, leaving a total of 116 patients in theWLE group
and 115 patients in the CE group completing the baseline
procedure according to the protocol (Fig. 1). Table 1
shows the baseline characteristics, which were similar for
the 2 groups. The mean age was 46.0 years (standard
deviation [SD], 11.5 years). In both groups, the most
common mutation type was MSH6, followed by MSH2 and
MLH1. Only a small number of EPCAM mutation carriers
were included. For 44 patients (19%), it was their first
colonoscopy. Of the 187 patients who had already
undergone one of more colonoscopies before inclusion,
89 (48%) had 1 or more adenomas on previous occasions.
Baseline colonoscopy
The baseline procedure characteristics are presented in
Table 2. CE took significantly more time than conventionalVolume 90, No. 4 : 2019 GASTROINTESTINAL ENDOSCOPY 627
TABLE 2. Characteristics of the baseline colonoscopy procedure
White-light
endoscopy
(n [ 116)
Chromoendoscopy
(n [ 115)
Total procedure time (minutes),
median (IQR)
22 (17-30) 31 (24-42)
Withdrawal time (minutes),
median (IQR)
12 (9-16) 19 (15-24)
High-definition scope used,
n (%)*
50/111 (45) 57/110 (52)
Bowel preparation, n (%)
Good 92 (79) 82 (71)
Fair 24 (21) 33 (29)
Adverse event rate 1/116 1/115
IQR, Interquartile range.
*Data not available for all cases.
TABLE 3. Endoscopic detection rates at baseline colonoscopy
White-light
endoscopy
(n [ 116), n (%)
Chromoendoscopy
(n [ 115),
n (%)
P
value
Patients with polyp(s) 59 (51) 64 (56) .46
Patients with
neoplasia
31 (27) 35 (30) .56
Patients with
advanced neoplasia
7 (6) 5 (4) .43
Patients with proximal
polyps
32 (28) 54 (47) .003
Patients with proximal
neoplasia
19 (16) 28 (24) .13
Chromoendoscopy and colorectal neoplasia detection in Lynch syndrome Haanstra et alcolonoscopy, with median total procedure times of 31
minutes versus 22 minutes, respectively (difference 9
minutes, P < .0001). This was due to a significantly
longer withdrawal time: 19 minutes for CE versus 12
minutes for WLE (difference 7 minutes, P < .0001).
Procedures were performed with a high-definition (HD)
colonoscope in 48% of cases where information regarding
the type of endoscopy was available, and this was not
different between the groups.
At the baseline procedure, 126 polyps were detected in
the WLE group, whereas 145 polyps were removed in the
CE group. Detection rates of the baseline procedure are
summarized in Table 3, and the histopathologic
characteristics of the lesions are presented in Table 4.
The neoplasia detection rate was similar in both groups:
27% for WLE and 30% for CE (OR, 1.23; 95% CI, 0.69-2.2;
P Z .56). The mean number of neoplastic lesions
detected per colonoscopy was 0.39 (SD, 0.72) for WLE
and 0.50 (SD, 0.95) for CE (P Z .29).
As CE was applied only in the proximal colon, a sub-
group analysis was performed with respect to location.
The polyp detection rate in the proximal colon was higher
in the CE group than in the WLE group: 47% versus 28%
(OR, 2.3; 95% CI, 1.3-4.0; P Z .003). The neoplasia detec-
tion rates in the proximal colon were similar: 28 of 115
(24%) for CE versus 19 of 116 (16%) for WLE (OR, 1.6;
95% CI, 0.9-3.1; P Z .13). The mean number of proximal
neoplastic lesions per colonoscopy was 0.22 (0.586) in
the WLE group and 0.38 (0.80) in the CE group (PZ .08).
Overall, 167 non-neoplastic lesions were detected in
both groups, mostly SSPs, equally divided between the 2
groups. Most SSPs were found in the distal colon. No
SSPs larger than 1 cm were found in the proximal colon.
The use of HD scopes versus non-HD devices was not
associated with higher detection rates of polyps, neoplastic
lesions, or SSPs (details not shown). Neoplasia detection
rates were not statistically different between the 6 centers
(Fisher exact test).628 GASTROINTESTINAL ENDOSCOPY Volume 90, No. 4 : 2019Follow-up colonoscopy at 2 years
Two years after the baseline investigation, colonoscopy
with CE was scheduled. For various reasons, 45 patients
were excluded at the time of the 2-year colonoscopy
(Fig. 1), mainly because of poor bowel preparation or
deviation from the predefined interval in the protocol.
This resulted in 186 patients completing the entire study
protocol: 92 patients from the original WLE group and 94
patients from the original CE group, and these patients
were included in the per-protocol analysis. CE in the
proximal colon was applied in these 186 patients at their
2-year colonoscopy. The median interval between the
baseline colonoscopy and the 2-year colonoscopy was 24
months (IQR, 23-25 months).
Procedures were comparable between groups regarding
procedure characteristics (Table 5). Median withdrawal
time was 18 minutes (IQR, 13-24 minutes), which was
similar to the withdrawal time in the CE group at
baseline colonoscopy. HD devices were used in 65% of
patients in the original WLE group and in 70% in the
original CE group (not significant).
Detection rates of the follow-up procedure after 2 years
are summarized in Table 6, and the histopathologic
characteristics of lesions are presented in Table 7. The
polyp detection rate was lower in the original CE group
than in the original WLE group: 40% versus 59% (OR,
0.48; 95% CI, 0.27-0.86; P Z .013). Neoplasia detection
rates were 26% in the WLE group and 28% in the CE
group (OR, 1.1; 95% CI, 0.57-2.07; P Z .81). The mean
(SD) number of neoplastic lesions detected per
colonoscopy was 0.41 (0.88) in the WLE group and 0.39
(0.91) in the CE group (P Z .88). Subgroup analysis was
performed according to lesion location. The neoplasia
detection rates in the proximal colon were similar
between the groups: 22% for the WLE group versus 22%
in the CE group. The mean number of proximal
neoplastic lesions per colonoscopy was 0.36 (0.86) in the
WLE group and 0.29 (0.76) in the CE group (P Z .55).
Similar to the baseline procedure, detection rates of
polyps overall, neoplastic lesions, and SSPs werewww.giejournal.org
TABLE 4. Clinicopathologic features of lesions detected at baseline
colonoscopy
White-light
endoscopy
(n [ 116)
Chromoendoscopy
(n [ 115)
Total number of lesions 126 145
Total number of neoplastic lesions 46 58
Number of neoplastic lesions according to histology
Adenoma with low-grade dysplasia 41 54
Adenoma with high-grade
dysplasia
4 4
Adenoma with serrated histology
(traditional serrated adenoma)
0 0
Carcinoma 1 0
Advanced neoplastic lesions 7 8
Number of neoplastic lesions according to location
Proximal 26 44
Distal 20 14
Number of adenomas according to size
5 mm 31 47
6-9 mm 9 10
10 mm 5 1
Number of non-neoplastic lesions 80 87
Number of non-neoplastic lesions according to histology
Sessile serrated polyps 54 31
Proximal <5 mm 11 12
Proximal 5-9 mm 5 2
Proximal >10 mm 0 0
Distal 38 17
Other (lymphoid tissue, normal
mucosa)
26 56
TABLE 5. Characteristics of the 2-year colonoscopy procedure
White-light
endoscopy group
(n [ 92)
Chromoendoscopy
group (n [ 94)
Total procedure time
(minutes), median (IQR)
29 (20-40) 29 (21-38)
Withdrawal time (minutes),
median (IQR)
17 (13-24) 19 (13-24)
High-definition scope
used, n (%)*
59/91 (65) 62/88 (70)
Bowel preparation, n (%)
Good 66 (72) 73 (78)
Fair 26 (28) 21 (22)
Adverse event rate 1/92 0/94
IQR, Interquartile range.
*Data not available for all cases.
Haanstra et al Chromoendoscopy and colorectal neoplasia detection in Lynch syndromecomparable in procedures that had been performed with a
HD colonoscopy compared with those performed with a
non-HD device. The neoplasia detection rates were not sta-
tistically different between the 6 centers (Fisher exact test).
At the follow-up procedure, 99 lesions were detected in
the original WLE group, whereas 88 lesions were removed
in the CE group. CRC was detected in 3 patients in the orig-
inal CE group during the procedure after 2 years, whereas
only 1 case of CRC was diagnosed in the WLE group. All
these CRCs were located in the proximal colon. Patient
characteristics of these patients with CRC found during
the follow-up procedure are shown in Table 8. In 2 of
these 4 patients, the level of bowel preparation was fair
during the baseline procedure. Three of these 4 patients
had one or more adenomas removed at the baseline
procedure. Three of the 4 patients had undergone the
baseline procedure with a non-HD device.
Colectomy rates were low in both groups throughout
the study period. After the baseline procedure, 1 patientwww.giejournal.orgin the WLE group underwent a colectomy because of
CRC compared with none in the CE group. After the 2-
year procedure, 4 patients underwent colectomy because
of CRC. No serious adverse events as a consequence of
the endoscopic procedures were observed in either group
throughout the study period.DISCUSSION
In this randomized controlled study in patients with LS
who were under surveillance, we found that neoplasia
detection rates were similar between WLE and CE, both
at baseline colonoscopy and at the follow-up colonoscopy
after 2 years. Although CE in the proximal colon was asso-
ciated with higher polyp detection rates at baseline,
neoplasia detection rates were similar. This is partly in
accordance with previous findings.7,18-20 So far, 4 studies
have prospectively assessed the value of CE in LS.7,18-20
In 3 studies, a conventional colonoscopy was directly fol-
lowed by colonoscopy with proximal CE18 or pancolonic
CE.19,20 These studies all showed that with the
second withdrawal by CE, additional adenomas were
detected.18-20 One study demonstrated that significantly
more adenomas were detected per patient (0.3 per
patient in CE vs 0.1 per patient in WLE).19 However,
these 3 studies are hampered by a back-to-back study
design.18-20 In such a study design, the colon of a particular
patient is examined twice in 1 procedure and this probably
introduced bias, because a second look will almost always
detect additional adenomas. Therefore, it is difficult to
compare the outcomes of these previous studies with
our study results. In another CE study, the patients were
randomized after conventional WLE to an immediate sec-
ond examination with either CE or WLE using a sophisti-
cated back-to-back-design.7 No significant difference inVolume 90, No. 4 : 2019 GASTROINTESTINAL ENDOSCOPY 629
TABLE 6. Endoscopic detection rates at 2-year colonoscopy for the
original white-light endoscopy and chromoendoscopy groups
White-light
endoscopy
group
(n [ 92),
n (%)
Chromoendoscopy
group
(n [ 94),
n (%)
P
value
Patients with polyp(s) 54 (59) 38 (40) .013
Patients with neoplasia 24 (26) 26 (28) .80
Patients with advanced
neoplasia
5 (5) 5 (5) .77
Patients with proximal
polyps
41 (45) 31 (32) .11
Patients with proximal
neoplasia
20 (22) 21 (22) .92
TABLE 7. Clinicopathologic features of lesions detected at 2-year
colonoscopy
White-light
endoscopy
group (n [ 92)
Chromoendoscopy
group (n [ 94)
Total number of lesions 99 88
Total number of neoplastic
lesions
39 37
Number of neoplastic lesions according to histology
Adenoma with low-grade
dysplasia
36 34
Adenoma with high-grade
dysplasia
2 0
Adenoma with serrated
histology (traditional
serrated adenoma)
0 0
Carcinoma 1 3
Advanced neoplastic lesions 5 5
Number of neoplastic lesions according to location
Proximal 34 30
Distal 5 7
Number of adenomas according to size
5 mm 27 26
6-9 mm 9 6
10 mm 2 2
Number of non-neoplastic
lesions
60 51
Number of non-neoplastic lesions according to histology
Sessile serrated polyp 29 13
Proximal <5 mm 10 5
Proximal 6-9 mm 5 1
Proximal >10 mm 1 0
Distal 13 7
Other (lymphoid tissue, normal
mucosa)
31 38
Chromoendoscopy and colorectal neoplasia detection in Lynch syndrome Haanstra et aladenoma detection was found, but the yield with
respect to subsequent polyp detection in the second
procedure was significantly higher with CE compared
with WLE.7 Recently a well-designed prospective random-
ized controlled trial in 61 patients with LS showed a signif-
icantly higher adenoma miss rate for HD WLE compared
with virtual CE/I-SCAN independently of inspection
time.26 Thus, most of the evidence suggests that CE
increases polyp detection in LS, but data are conflicting
regarding the effect of CE on the detection of neoplastic
lesions.
We found no difference in neoplasia detection rates be-
tween CE and WLE at the baseline investigation. Based on
the literature, it was expected that the neoplasia detection
rate at baseline would be around 20% using WLE, and that
the rate for CE would be double that. What we found was
that the neoplasia detection rate was actually higher than
expected in the WLE group (27%) and lower than expected
in the CE group (30%). The question is why CE of the prox-
imal colon was not associated with a difference in
neoplasia detection rates, although we found a trend to-
ward higher neoplasia detection rates in the proximal co-
lon at the baseline investigation using CE (24%) versus
WLE (18%). We cannot rule out the possibility that our
study was insufficiently powered to demonstrate a differ-
ence. Another explanation may lie in the fact that in about
half of the baseline procedures, HD colonoscopes were
used, which may have contributed to the relatively high
neoplasia detection rate in the WLE group. This may
have introduced some bias because a higher adenoma
detection rate has been demonstrated with HD white-
light colonoscopy compared with conventional white-
light colonoscopy,12,15 although this was not observed in
our data.
It may well be that the additional value of CE is negli-
gible in procedures where HD devices are used, as was
recently demonstrated in surveillance of patients with in-
flammatory bowel disease.27,28 Another explanation why630 GASTROINTESTINAL ENDOSCOPY Volume 90, No. 4 : 2019detection rates were similar between CE and WLE may
be the relatively high proportion of MSH6 mutation car-
riers (approximately 40%) in this study. These persons
have a significantly lower cumulative CRC risk compared
with MLH1 and MSH2 mutation carriers.6 By including a
relatively large group of MSH6 mutation carriers possibly
fewer adenomas were detected than expected.
Optimization of adenoma detection by CE and subse-
quent removal at the initial colonoscopy could be impor-
tant for patients, because it may reduce the incidence of
neoplasia during follow-up. Our study is the first to our
knowledge in which the effect of CE on neoplasia detec-
tion was examined in 2 consecutive colonoscopy proced-
ures over a 2-year observation period. Our results after 2
years did not demonstrate that CE has a benefit overwww.giejournal.org
TABLE 8. Characteristics of the 4 patients with CRC at the follow-up procedure
Case 1 Case 2 Case 3 Case 4
Age (years), gender 66, female 30, male 47, female 54, female
Tumor location Ascending Ascending Ascending Ascending
Interval between procedures (months) 22 26 28 22
Tumor stage I III I I
Bowel preparation at baseline procedure Fair Fair Good Good
Chromoendoscopy at baseline procedure No Yes Yes Yes
Findings at baseline procedure 3 proximal adenomas No abnormalities 2 proximal adenomas 3 proximal adenomas
High-definition scope used at baseline procedure Yes No No No
Haanstra et al Chromoendoscopy and colorectal neoplasia detection in Lynch syndromeWLE in the ability to reduce the occurrence of colorectal
neoplasia during surveillance. Our follow-up data are
limited to a period of only 2 years, which is probably too
short to detect a possible protective effect of CE on the
incidence of colorectal neoplasia. Clearly, long-term
follow-up studies are warranted to determine whether CE
is indeed able to reduce CRC risk in patients with LS.
Our study has several strengths. It is the largest CE
study in proven MMR gene mutation carriers thus far. We
stratified patients according to the presence or absence
of adenomas during previous procedures, a strategy that
was not applied in earlier studies. The aim here was to
reduce potential bias introduced by the fact that some pa-
tients may develop neoplasia more rapidly than others. As
mentioned before, our study is novel in that it is the first to
prospectively assess the possible influence of CE on the
detection of colorectal neoplasia during follow-up,
including a 2-year observation period.
Our study has some limitations apart from the con-
founding factor introduced by the use of HD devices in a
subset of patients. One is that the study was powered to
detect a difference in neoplasia detection rate at baseline
based on previous pancolonoscopy CE detection rates,
whereas in fact only the proximal colon was investigated
by CE, as we expected the highest yield of the technique
in this part of the colon. This calls for caution when inter-
preting the results. Another limitation of our study was
that we did not use a validated scale to assess bowel prep-
aration. Finally, the classification of sessile serrated lesions
as non-neoplastic lesions in our study may be disputed. It
must be realized that the currently widely used 2010 World
Health Organization classification of this type of lesions29
had not yet been published when our study was
designed. The role of the sessile serrated pathway in LS is
unclear but may be comparable with that in the general
population.29
In conclusion, although CE increased the detection rate
of colorectal lesions in patients with LS at baseline, detection
rates of colorectal neoplasia were similar between the
groups both at baseline and at the follow-up colonoscopy
after 2 years. Our results do not clearly support a benefitwww.giejournal.orgof CE over white-light colonoscopy during surveillance in
patients with LS, although long-term follow-up studies are
warranted to determine whether CE is able to reduce CRC
risk.
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